In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Pocket Guidelines on Management of Arterial Hypertension

ESC Pocket Guidelines

Chronic Nursing Care
Pathophysiology and Mechanisms
Risk Factors and Prevention
Epidemiology, Prognosis, Outcome
Diagnostic Methods

Publication Date: 2018

Chairpersons: Bryan Williams and Giuseppe Mancia

Order Pocket Guidelines


Table of Contents

1. Introduction

1.1 Principles

1.2 What is new and what has changed in the ESC/ESH 2018
Arterial Hypertension Guidelines?

2. Diagnostic Aspects

2.1 Classification of blood pressure and definition of hypertension

2.2 Assessment of Cardiovascular Disease (CVD) Risk

2.3 Blood Pressure Measurement

2.4 Home blood pressure monitoring

2.5 Ambulatory blood pressure monitoring (ABPM)

2.6 Screening for the detection of hypertension

2.7 Confirming the diagnosis of hypertension

3. Clinical evaluation 

3.1 When to refer a patient with hypertension for hospital-based care 

4. Treatment of Hypertension

4.1 BP thresholds for treatment

4.2 BP treatment targets

4.3 Treatment of Hypertension – Lifestyle interventions

4.4 Treatment of Hypertension – Drug therapy

4.5 The drug treatment algorithm for hypertension

4.6 Device-based hypertension treatment

5. Resistant Hypertension

5.1 Definition of resistant hypertension

5.2 Causes of pseudo-resistant hypertension

5.3 Treatment of Resistant Hypertension

6. Secondary hypertension

7. Hypertension Emergencies

8. Hypertension in pregnancy

8.1 Definition and classification of hypertension in pregnancy

9. Masked and White Coat Hypertension

9.1 White Coat Hypertension

9.2 Masked Hypertension

 10. Hypertension in patients with specific co-morbidities

 11. Managing concomitant cardiovascular disease risk and patient

11.1 Use of statins and anti-platelet therapy

11.2 Follow-up of hypertensive patients